Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome


YETER H. H., DERİCİ Ü., ARINSOY S. T., ALTOK K., ERTEN Y., GÜZ G.

ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE, cilt.60, sa.1, ss.56-65, 2022 (ESCI) identifier identifier